The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
120610852 12061085 2 F 20110824 20160805 20160210 20160812 EXP BR-ABBVIE-16K-020-1554327-00 ABBVIE 56.43 YR F Y 78.00000 KG 20160812 CN COUNTRY NOT SPECIFIED BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
120610852 12061085 1 PS HUMIRA ADALIMUMAB 1 Subcutaneous UNKNOWN 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
120610852 12061085 2 C METHOTREXATE. METHOTREXATE 1 Oral 0 2 DF TABLET /wk
120610852 12061085 3 C FOLIC ACID. FOLIC ACID 1 Oral 0 1 DF TABLET /wk
120610852 12061085 4 C FOLIC ACID. FOLIC ACID 1 0
120610852 12061085 5 C FOLIC ACID. FOLIC ACID 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
120610852 12061085 1 Ankylosing spondylitis
120610852 12061085 2 Spondylitis
120610852 12061085 3 Spondylitis
120610852 12061085 4 Gastrointestinal injury
120610852 12061085 5 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
120610852 12061085 HO
120610852 12061085 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
120610852 12061085 Bile duct stenosis
120610852 12061085 Feeling hot
120610852 12061085 Finger deformity
120610852 12061085 Hypersensitivity
120610852 12061085 Inflammation
120610852 12061085 Injection site erythema
120610852 12061085 Injection site pain
120610852 12061085 Injection site papule
120610852 12061085 Injection site swelling
120610852 12061085 Injection site warmth
120610852 12061085 Intestinal obstruction
120610852 12061085 Local swelling
120610852 12061085 Mouth swelling
120610852 12061085 Neck pain
120610852 12061085 Oral pruritus
120610852 12061085 Pain
120610852 12061085 Pruritus
120610852 12061085 Stomatitis
120610852 12061085 Swelling face
120610852 12061085 Wound

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
120610852 12061085 1 20110824 0
120610852 12061085 2 2011 0
120610852 12061085 3 2011 0